There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Provention Bio (PRVB – Research Report), Applied Molecular Transport (AMTI – Research Report) and Rocket Pharmaceuticals (RCKT – Research Report) with bullish sentiments. Provention Bio (PRVB) SVB Securities analyst Thomas Smith reiterated a Buy rating on Provention Bio on May 19 and set a price target of $16.00. The company's shares closed last Friday at $3.96, close to its 52-week low of $3.40. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-provention-bio-prvb-applied-molecular-transport-amti?utm_source=advfn.com&utm_medium=referral